[Optimal doses and timing for tele-irradiation of bone metastases in patients with life expectancy more than 3 months].

The aim of the current study was to improve the bone metastases irradiation parameters in patients with life expectancy more than 3 months. The current randomized study included a total of 333 patients with bone metastases (breast cancer metastases in 71% of cases) receiving 488 courses of photon irradiation. Irradiation effect was observed in 95.8-100% of cases regardless of fraction number and irradiation regimen. The rate of complete effect was the same for all irradiation regimens, but raised gradually from 33.3% to 50.4% and 65.9% respectively when irradiation was given by 2, 3 and 4 fractions, 6,5 Gy each (p < 0.03); 78.4% (p < 0.01) cases of complete effect were observed in patients receiving irradiation by multiple small fraction compared to the groups receiving irradiation by 2 or 3 fractions of 6.5 Gy. The complete effect was more often observed in breast cancer (67%) and prostate cancer (63%) patients in comparison to lung cancer (47%) and renal cancer (30%) patients (p < 0,05) independent of metastases localization. The mean frequency of pain recurrence in irradiated area was 8.2% in all primary tumor and metastases localizations, irrespective of irradiation dose and regimen. Based on above results we recommend for breast cancer and prostate cancer patients with bone metastases and life expectancy more than 3 months the irradiation with 19.5 Gy given by 3 fractions. The patients with metastasizing lung and renal cancer should receive 26 Gy irradiation by 4 fractions 6.5 Gy each given once every 5.

[Some prognostic factors in the combined therapy of locally advanced breast cancer]. / Hekotorye prognosticheskie faktory v kompleksnom lecheniie mestnorasprostranennogo raka molochnoi zhelezy.

A relationship between the dynamics of growth and pathological response of tumor cells and the number of neoadjuvant chemotherapy courses was established. As a result, there was no correlation between increase in overall and disease-free survival, on the one hand, and stage, on the other. An interval between neoadjuvant chemotherapy and surgery longer than 4 weeks had a negative effect on overall tumor response and duration of disease-free period.

[Role of induction chemo- and radiotherapy in the treatment of locally advance breast cancer]. / Znachenie induktsionnoi luchevoi i khimioterapii v lechenii mestnorasprostranennogo raka molochnoi zhelezy.

336 patients with locally-advanced breast cancer underwent neoadjuvant chemotherapy or chemoradiotherapy. Increase in T- and N-indices (change of stage after neoadjuvant chemotherapy) proved an important prognostic factor. Survival rates correlated with clinical effect and dropped as it diminished. This tendency was clear in both groups. There was no relationship between stage and overall and disease-free survival rates at early stages but later they declined as T- and N-indices decreased.

[Correlation of clinical effect, pathological response of tumor cells and the end results of combined treatment of locally advanced breast cancer]. / Korrelatsiia klinicheskogo éffekta, patomorfoza opukholevykh kletok i otdalënnykh rezul'tatov kompleksnogo lecheniia bol'nykh s mestnorasprostranennym rakom molochnoi zhelezy.

A correlation was established between the end-results of neoadjuvant chemotherapy for locally-advanced breast cancer and pathological response of tumor cells. Also, the end-results correlated with CR or PR and pathological response. Only a small proportion of patients with tumor progression were registered as stage III or IV of pathological response (0.6 and 0.8%, respectively).

[Radiation resistance of animals subjected to lethal irradiation with chemical protection]. / K voprosu o radiorezistentnosti zhivotnykh, perenesshikh letal'noe obluchenie v usloviiakh khimicheskoi zashchity.

The data are presented on radioresistance of mice 1, 5 and 9 months after irradiation (LD95-99/30) in conditions of protection with cystamine. It was shown that the resistance of these animals to repeated irradiation with LD50/30 is considerably lower than that of the animals not exposed previously. The radioresistance and such indices of the haemopoietic system status as quantity of caryocytes and colony-forming capacity of the bone marrow are compared.